Why the study?
Do antihypertensive drugs reduce stroke incidence and other cardiovascular events in primary prevention?
Population
Patients receiving primary stroke prevention (hypertensive patients)
Design
Review
Authors
Loading...
Supports antihypertensives for primary stroke prevention; leaves open optimal targets and net benefit in low-risk contemporary cohorts.
Do antihypertensive drugs reduce stroke incidence and other cardiovascular events in primary prevention?
Antihypertensive drugs provide significant benefits in primary stroke prevention (40% reduction) and other cardiovascular outcomes, though risks and costs must be considered.
Christopher J. Bulpitt (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: